Form 4: National Health Investors CEO D. Eric Mendelsohn Reports Stock Transactions

D. Eric Mendelsohn, CEO and President of National Health Investors, reports the disposition of shares for tax settlement and ongoing stock option holdings.

Summary

• On February 23, 2025, D. Eric Mendelsohn, CEO and President of National Health Investors, disposed of 267 shares of common stock at a price of $68.96 for tax settlement purposes.
• Following this transaction, Mendelsohn directly owns 88,527 shares of National Health Investors common stock.
• Mendelsohn also holds multiple stock options, including options to buy 41,666 shares exercisable on 02/25/2021, 41,666 shares exercisable on 02/25/2022, 41,668 shares exercisable on 02/25/2023, 13,333 shares exercisable on 02/23/2025, 13,334 shares exercisable on 02/23/2026 and 13,334 shares exercisable on 02/24/2025.
• These options have exercise prices of $69.20, $57.76 and $54.73 and expire on 02/25/2026, 02/23/2029 and 02/24/2028 respectively.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports required insider trading activity. There is no indication of positive or negative performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
• Comparable companies in the REIT sector, such as Welltower (WELL) and Ventas (VTR), also have executives who regularly file Form 4s to report similar transactions.

Key Dates